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INCIDENCE AND OUTCOME OF CUTANEOUS MALIGNANCIES IN     
   COIMBATORE MEDICAL COLLEGE HOSPITAL COIMBATORE.  
Abstract: 
Introduction: 
The incidence of skin cancers are increasing worldwide. Prolonged 
and excessive exposure to UVB rays of sunlight is the major risk factor 
for skin cancers. Even though skin cancers are rare in India, Non 
Melanoma Skin Cancer (NMSC) is increasing in Indian population. Skin 
cancers are curable once diagnosed and treated early.  
Background: 
Study period - from September 2011 to November 2012. Study 
population taken from Coimbatore medical college hospital from surgery, 
dermatology and plastic surgery departments. 
Objectives of the study:   
 To study about the incidence, clinical and anatomical presentation 
of various types of cutaneous malignancies and its histological features, 
the various appropriate treatment modalities available in our hospital and 
the morbidity and mortality with available facilities and modalities of 
treatment. 
Results:  
 As compared with previous studies the incidences of skin cancers 
have increased at present. 45 cases of skin cancers were diagnosed. SCC-
(69%), BCC-(22%), MM-(9%). SCC had their higher incidence among 
our patients. Most of the lesions presented in lower limb and foot. Most 
patients were between 40-70 years of age. BCC and SCC together had 
increase in incidence in female population.  
 More number of BCC was diagnosed in females. MM had the low 
incidence in our population. In case of diagnosed patients, we were able 
to give complete cure at most possible. 
Conclusion:  
        Skin cancer is becoming more common cancer among the Indians 
due to their excessive and prolonged exposure to UVR of sun light. It is 
totally curable once diagnosed and treated at early. The best modality of 
the diagnosis is by subjecting the lesions for biopsy. By obtaining the 
proper history, clinical examination and strong suspicion on each and 
every non healing ulcer, changes in the mole one can diagnose skin 
cancers early. The best modality of treatment in our setup is surgery.      
 
 
Key Words:  
        Non melanoma skin cancer, cutaneous malignancies, squamous 
cell carcinoma, basal cell carcinoma, malignant melanoma. 
Foot Notes: SCC- Squamous Cell Carcinoma, BCC- Basal Cell 
Carcinoma, MM- Malignant Melanoma, UVR- Ultraviolet Rays, UVB- 
Ultraviolet Rays B. 
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Introduction 
INTRODUCTION 
Skin cancers have been increasing worldwide in last few decades. 
Mainly occurs in sunlight exposed areas due to UVB rays of wave length 
of 280-320nm.Melanin has the protective effect for those UV rays 
causing skin malignancies. Even though Indians having low incidence of 
skin malignancies Non Melanoma Skin Cancers (NMSC) are in raising 
trend. 
Exposure to chemical carcinogens like tar, arsenic, nitrogen 
mustard increases   the risk of skin malignancies. HPV infection, 
Immunologic dysfunction, radiotherapy over skin lesions, immuno 
compromised patients receiving chemotherapy those with HIV/AIDS, 
immunocompromised transplant recipients, chronically irritated non 
healing ulcers also having elevated risk of developing cutaneous 
malignancies. 
Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), 
Malignant Melanomas are the common cutaneous malignancies, having 
their malignant potential in their ascending order. In India SCC is more 
common than BCC.  
Early diagnosis and appropriate treatment of cutaneous 
malignancies not only reduces the morbidity and also provides good 
quality of life and survival of the individuals.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objectives of the Study 
 
OBJECTIVES OF THE STUDY 
1. To study about the incidence, clinical and anatomical 
presentations of various types of cutaneous malignancies and its 
histological features. 
2. To study about the various appropriate treatment modalities 
available in our hospital.  
3. To study about the morbidity and mortality with available 
facilities and modalities of treatment. 
  
  
 
 
 
 
 
 
 
 
 
Methodology 
METHODOLOGY 
Men and material: 
Study population taken up from patients in Coimbatore Medical 
College Hospital, Coimbatore, from the department of surgery, 
dermatology and plastic surgery with due permission obtained from the 
collaborating departments. 
Period of study:   
      With the guidance of professor. Dr.V.Elango M.S, FAIS., the study 
was conducted between September 2011 –November 2012.  
Study Type:  Observation Study  
Inclusion criteria: 
1)   Adult patients with chronic non healing skin ulcers, 
2)   Suspected cutaneous malignant lesions, 
3)  Patients with sudden increase in size or colour change in pre existed 
mole.  
Exclusion Criteria:   
1) Age < 18yrs, 
2) Pregnant women, 
3) Psychiatric patients, 
4) Other malignancies and malignancies of external genitalia and anal 
region. 
       Informed consent was obtained from the patients. Proforma was duly 
filled and detailed history was obtained. Patients with chronic non healing 
skin ulcers and with suspected cutaneous malignant lesions were 
examined and diagnosed clinically. Initially the patients were subjected 
for biopsy from the lesions, routine basic investigations, vctc, Chest X 
ray; ECG, usg abdomen, CT scan and fnac from nodes for reliable 
patients were done. For small single lesion excision biopsy was done as 
diagnostic and therapeutic procedure.   
       Specimens sent for histopathological examination correlated with 
clinical diagnosis. 
       Patients were treated as in patients as well as opd. Studies were 
conducted on various types of skin malignancies diagnosed, their 
incidence, various modalities of treatments executed in cmch and their 
outcome. Patients were followed periodically after the discharge. 
Analysis data were reported according to age, sex distribution, various 
types of skin malignancies among them, anatomical presentation and their 
distributions, procedures done and the outcome.  
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REVIEW OF LITERATURE 
ANATOMY OF THE SKIN 
Skin is not only just an envelope of the human body but also a largest 
organ. Surface area ranges from 0.25 square meters in new born and 
about 1.8 square meters in the adult .Accounts for 15% of total body 
weight.  Skin consists of two components,  
1. Epidermis (Surface ectoderm) 
2. Dermis      (Mesoderm) 
Epidermis consists of stratified squamous epithelium. The cells in this 
layer as they mature move from the basal layer towards the surface. 
Neoplasms develop following the disturbance of cell maturation. Layers 
of epidermis are five in number. 
1. Basal Layer 
2. Stratum Spinosum 
3. Stratum Granulosum 
4. Stratum Lucidum 
5. Stratum corneum 
1. BASAL LAYER: 
It is the deepest layer, known as stratum basale. Made up of single 
layer of columnar epithelium rests over the basal lamina. Basal layer 
contains stem cells which produces keratinocytes hence called as 
germinal layer / stratum Germinativum. 
2. STRATUM SPINOSUM: 
   Otherwise known as Malphagian layer. This layer is formed by 
several layers of polygonal keratinocytes over the basal layer. The cells 
are attached to each other by desmosomes. The keratinocytes in this layer 
are known as prickle cells. 
3. SRATUM GRANULOSUM:  
This layer consists of 1-5 layers of flattened cells with deeply 
staining granules in their cytoplasm. Granules consist of protein known as 
keratobyalin. Nuclei in this layer are condensed and dark staining. 
4. STRATUM LUCIDUM: 
This layer is so called because of its homogenous appearance; the 
cell boundaries being extremely indistinct. Lies superficial to the stratum 
germinatum. 
5. STRATUM CORNEUM: 
  This is the superficial acellular layer of the epidermis. This layer is 
made of flattened scale like elements known as squames. They contain 
keratin filaments embedded in proteins. The squames are held together by 
glue like material contains lipids and carbohydrates. Presence of lipids 
resists the permeation of water. The thickness of this layer is more in 
friction areas like palms and soles. Stratum Corneum, Stratum Lucidum, 
Stratum Granulosum together known as zone of keratinization / cornefied 
zone. 
Pigment system: 
Pigment (melanin) in the epidermis is produced by melanocytes, 
which are the derivative of neural ectoderm. Melanin is transferred by 
phagocytosis into the adjacent keratinocytes. The increase in skin 
pigmentations produced by the exposure to sunlight is due to increased 
production of the melanin and not due to increased production of 
melanocytes. 
DERMIS: 
This is the supportive layer of epidermis and adnexa. Provides 
nourishment to them. Composed of blood vessels, lymphatics and 
network of sensory and vasomotor nerves. 
Layers of the dermis: 
1. Superficial Papillary layer:  
Contains fine collagen, elastic and reticulin fibers. These fibers run 
vertical to the skin surface. They supports to the capillary loops, lymph 
vessels and nerve endings. 
 
2. Deeper reticular layer: 
  Contains network of thick collagen bundles. They run parallel to 
the skin surface. They contribute to the Langers cleavage lines. Surgical 
incisions along these lines will produce minimal scar on healing. 
Basement membrane: 
The lamina between the epidermis and dermis is known as 
basement membrane. Carcinoma insitu by crossing this lamina changes 
into invasive carcinoma. 
SKIN APPENDAGES: 
 Sweat glands, Sebaceous glands, Hairs and Nails. These are the 
specialized derivatives of the epidermis. 
Sweat glands: 
 These are coiled tubular structures that extend into dermis and sub 
cutaneous tissue. They are seen in both the hairy and non hairy areas 
except in the lips, margins of nipple, labia minora, inner surface of 
prepuce and glans penis. They are abundant in face, palms and soles. 
These glands are supplied by cholinergic fibers in sympathetic nerves. 
They secrete an odourless fluid (sweat) on the skin surface. Bacterial 
action is responsible for the odour. 
 
 
Apocrine glands:  
 These are the modified sweat glands mostly seen in axilla, areolae, 
sub umbilical, genital and perianal regions. They are supplied by 
adrenergic fibers in sympathetic nerves. They secret viscous odoriferous 
fluid into the hair follicle. 
Sebaceous glands: 
These are small saccular structures, open into the side of hair 
follicles. On the skin of lips, nipple, areolae, inner surface of prepuce, 
glans penis, labia minora are the areas where directly opens on to the 
surface. They liberate sebum into the hair follicles. These glands are 
absent in palms and soles. 
Hairs:   
These are the hard type of keratin. Developed from the hair matrix, 
which extends to the dermis and sub cutaneous tissue. Hair follicle is the 
invagination of the epidermis. Terminal expansion of hair follicle is 
known as hair bulb, where the hair growth takes place. Hair follicle with 
its sebaceous glands and erector pili muscle together known as 
Pilosebaceous unit. 
 
 
 
Nails:  
These are the keratin structures. They grow from transverse  
infolding of epidermis into dermis. Nail bed contains rich in blood and 
nerve supply. 
VARIOUS TYPES OF SKIN LESIONS: 
MACULE :  Circumscribed flat lesion. 
PAPULE :  Circumscribed elevated area up to 5mm 
NODULE :  Papule between 0.5 to 2 cm, deep seated, 
involves the lower dermis & subcutaneous 
tissue. 
SCALE :  Loosened, imperfectly cornefied, 
parakeratotic superficial layer.  Shed as fine 
flakes.  
CRUST       :  Residue of dried blood, serum, pus, and 
bacterial derbies  
ACANTHOSIS :  Thickening of stratum Spinosum due 
chronic irritation. 
HYPER KERATOSIS  :  Thickening of stratum corneum. 
PARA KERATOSIS   :  Persistence of nuclei in stratum corneum  
with  reduction in granular layer. 
DYSKERATOSIS :  Distinctive alteration of epidermal cells., 
MALIGNANT   :  Hyperchromatism, polarity changes,  
DYSKERATOSIS  increased mitotic activity, enlargement of                                                                
nuclei and nucleoli. 
PSEUDO  :  Pronounced acanthosis with down growth  
EPITHELIOMATOUS   of rete pegs. 
HYPERPLASIA                                 
 
                             
 
 
          
  
AETIOLOGY OF THE SKIN CANCER 
NON MELANOMATOUS SKIN CANCERS (NMSC) 
• Multifactorial 
a) Environmental factor,  
b) Chemical carcinogens, 
c) Viral factors, 
d) Radiation, 
e) Chronic irritation, 
f) Chronic inflammatory skin diseases. 
ENVIRONMENTAL FACTOR:  
Exposure to the sunlight is the responsible for the development of 
skin cancers. UV-B radiation is a carcinogen acts as both initiator and 
promoter, the wave length ranges from 280nm-320 nm. The wave length 
of 290-300 nm is the potent carcinogenic, produces basal cell carcinoma, 
squamous cell carcinoma and melanoma. Fair and thin skinned persons 
having higher incidence of developing skin cancers than darks. 
 
 
Mechanism: 
By affecting the processing of antigen by langerhan’s cells and 
Tcell proliferation, by altering the production of keratinocytes derived 
factor. Keratinocytes and Langerhan cells are damaged. Cellular changes 
involved in DNA mutations which produce abnormal pyramidine 
dimmers lead to skin cancers. Xeroderma Pigmentosum is an autosomal 
recessive disorder, in which deficit in repair of DNA defect caused by 
UV rays. These patients has high incidence of developing NMSC and 
Melanoma cancers. 
CHEMICAL CARCINOGENS: 
Chronic arsenic exposure due to contaminated drinking water, 
herbicides and pesticides can produce multiple SCC and BCC. Chronic 
exposure to soot causes the scrotal cancer (SCC) in chimney sweepers.  
Topical coal tar use with UV rays for inflammatory skin disorders in the 
past, medications such as Fowler’s solution, Quinacrine therapy may 
cause SCC. 
VIRAL ETIOLOGY: 
Human Papilloma Virus 5, 16, 18 can produce SCC more in 
immuno suppressants and transplant recipients. Warty lesions over the 
external genitalia may be changed into SCC (Verrucous type).  
Cyto megalo virus in aids patients may cause Kaposi’s sarcoma. 
RADIATION:  
Post radiation skin cancers are more aggressive. Radiotherapy used 
for the treatment of acnevulgaris, tenia capitis and for facial hairs in the 
past leads to radiation dermatitis has the high incidence of SCC, BCC and 
spindle cell carcinoma. 
CHRONIC IRRITATION: 
BCC having higher incidence than SCC in tumors arising from the 
vaccination scars. SCC may arise from, repeated trauma over the non 
healing ulcers; burnscar ulcers (marjolin’s), discharging sinuses of 
osteomyelitis and chronic leg ulcers (venous stasis ulcers), fistulous tracts 
and amputated stumps, 
Chronic heat injury - Kashmir Kangri cancer over the lower 
abdomen and thigh,  Kang cancer over the buttocks heels and elbow, 
scrotal cancer in chimney sweeper, saree or dothi cancer of abdominal 
wall, carcinoma of lower lip known as agricultures cancer. 
CHRONIC INFLAMMATORY DISEASES of the skin: 
Discoid lupus erythematosis, Bullous disease with repeated 
sloughing, chronic hypertrophic lichen planus has increased incidence of 
developing SCC.     
 
MALIGNANT MELANOMA 
 About 50% of melanoma develops from preexisting mole. 
Etiological factors are, 
a) Sunlight 
b) Host factors 
c) Heriditary 
d) Naevi 
e) Hormonal factors 
SUNLIGHT: 
 Intense, intermittent sun light exposure on non sun acclimatized 
skin areas has high risk of developing malignant melanoma. 
HOST FACTORS: 
         Light complexion 
         Light eyes (Blue / Green) 
         Blond / Red hair 
         Tendency to tan poorly and sun burns easily 
         Blistering sun burns in childhood, P 16 –CDK 4 gene mutation 
HERIDITARY: 
         a) Xeroderma Pigmentosum 
         b) Albinism 
        c) Li-Fraumen’s Syndrome 
        d) Dysplastic Nevus Syndrome. These are the conditions associated 
with high incidence of melanoma cancers. About 10%- 14 % runs in 
family. 
NAEVI: 
The conditions associated with melanoma are, 
         a) Congenital giant naevi 
         b) Junctional Naevi 
         c) Large number of naevi / dysplastic lesions 
         d) Atypical naevi  
HORMONAL FACTORS: Role of hormones is unclear. But has a role 
in female.  
 In general, individuals with one type of skin cancer develop a new 
or recurrent skin cancer within 18 months, with life time risk of 22-50%. 
Immuno compromised patients, renal transplants receiving immuno 
suppressant having high risk of developing skin cancers. The later having 
35 times higher risk for SCC and 7 times of increased risk for combined 
cancers.  Patients with tobacco use, chronic lymphocytosis, leukemia also 
have higher incidence of developing skin cancers.      
 Socio economic status, climate, life style, ethnic origin are the risk 
factors interact with the sun exposure.                                               
PRE MALIGNANT CONDITIONS 
 The premalignant conditions of NMSC are epithelial in origin. 
They are commonly with characteristics of chronic inflammatory 
infiltration in to papillary dermis.  
They are more prone to develop cancers. 
1) Actinic Keratosis / Senile keratosis /Keratosis Senilis.  
2) Cutaneous Horn. 
3) Bowen’s disease. 
4) Disseminated superficial ‘actinic’ parakeratosis. 
5) Erythroplasia of Queyrat. 
6) Bowenoid papulosis of the genitalia. 
7) Xeroderma Pigmentosum. 
8) Leckoplakia.  
9) Intra epithelial carcinoma of the eyelid margins. 
10) Leukokeratosis of the lips. 
11) Radio dermatitis.  
12) Arsenical keratosis. 
13) Congenital dermatosis. 
14) Paget’s disease of skin. 
15) Tar keratosis. 
ACTINIC KERATOSIS / SENILE KERATOSIS / KERATOSIS 
SENILIS: 
These are multiple, irregular, small scaly / warty lesions seen over 
the sun exposed areas due to hyperkeratosis. Clinically, they are usually 
dry, rough, and adherent and appear dirty brown in colour. The lesions 
occur in fair skin individuals with in middle ag groups. Sites: Mostly 
seen over face, back of hands and forearm. Especially ears in male. 
Malignant changes occurs in very few. The lesions with the induration at 
the base will progress into squamous cell carcinoma within years. They 
are slow growing and rarely metastaize. Pathologically, dyskeratosis of 
Basal and Malphagian layers seen. The cells are hyper chromatic with 
mitosis and loss of polarity. The nuclei are irregular in size and shape. 
Differential diagnosis:  
a) Seborrhoeic keratosis 
b) Solar Keratosis 
c) Bowen’s disease 
d) Superficial BCC 
e) Discoid Lupus Erythematosis 
f) Psoriatic Seborrhoeic dermatitis. 
  
TREATMENT: Depends upon the lesion. 
1) Cryotherapy          : For superficial lesions. Liquid nitrogen is 
used. 
2) Curettage / diathermy :  Best to treat horny lesions.       
3) Excision biopsy            :  Usually done for large and indurative 
lesions. 
4) Systemic drugs             :  Retinoid (Isotrentoin) for 3 to 6 months. 
5) Topical drugs               :  Used to treat multiple lesions on the face. 
5Fluro Uracil (5FU) cream twice daily 
for 3 to 4 weeks.  
6) Others    :  INF alpha II, Beta /Gamma Interferon. 
Intralesional admistration twice weekly. 
For 3 to 4 weeks. Effective for treating 
the lesions not able to be treated by above 
methods. 
7). Radiotherapy              :  Contraindicated. 
  
CUTANEOUS HORN: 
This is a clinical diagnosis by its appearance and its clinical course. 
Horny plugs or out growths may be due to various epidermal changes. 
Horns are usually friable in nature. Caused by epidermal naevi, viral 
warts, molluscum contagiosum, kerato acanthoma, Seborrhoeic keratosis 
and marsupialized epidermoid or trichilemmal cyst. Clinically, the lesion 
appears mostly in sun exposed areas mainly over the upper part of face 
and ears. The lesion is usually single or multiple. They are hard yellowish 
brown horn, curved and having circumferential edges. Inflammation of 
the base is due to recurrent trauma. Inflammation and induration reflects 
the underlying malignant transformation. Pathologically, the epidermal 
cells appear with normal polarity. Granular layer may be deficit /absent. 
In long standing lesions budding from basal layer indicates the 
development of SCC. 
BOWEN’S DISEASE:  
 It is a squamous cell carcinoma of intra epidermal form with 
small invasive malignant potency. They appear as persistent, progressive, 
usually non elevated, red, scaly, or clustered plaque. Occasionally 
spontaneous partial regression occurs. 
Exposure to sun light and arsenic are the common etiological 
factors. Mostly occurs in whites, over the lower legs of elderly women. 
Within 6 to 7 years about 50% of the patients develop skin malignancy. 
Clinically, the initial lesions are asymptomatic. They are seen as small 
red, scaly areas. They gradually and irregularly enlarge in size. The scale 
is white or yellowish in colour can be easily detachable without any 
bleeding from the surface leaving moistened reddened surface. The 
margins well defined. The lesion slightly raised and surface usually flat 
but may be hyperkeratotic or crusted. Ulceration usually denotes the 
invasive growth. Pigmentation /punctate palmoplantar keratosis are the 
features of chronic arsenicalism suggests of visceral malignancy mainly 
in lung. Pathologically, atypical proliferation of squamous cells 
throughout the whole thickness of the epidermis is seen. Disturbance of 
the epidermal organization, premature keratinization of cells with loss of 
their intercellular connection are the other features. Arsenical Bowen’s 
disease is charecterised by numerous vacuolated atypical cells.  
Differential diagnosis: 
a) Lichen simplex. 
b) Psoriasis 
c) Papulosquamous dermatosis 
d) Superficial (pagetoid) BCC 
 
 
TREATMENT: 
 Depends upon site, size and number of the lesions, previous 
treatment, various treatment experiences etc. 
1) Surgical Excision: Best modality of treatment for smaller 
lesions, poor wound healing sites, digital lesions, perineal lesions 
and to overcome recurrence. 
2) PDT (Photo Dynamic therapy), Laser destruction. 
3) Cryo surgery, Curettage and cautery.           
4) Radio therapy in full tumor dose.           
5) 5 FU 5% cream once daily for 4 to 8 weeks, once weekly in case 
of prolonged treatment, imiquimode topical application for 
smaller lesions.  
DISSEMINATED SUPERFICIAL ‘ACTINIC’ POROKERATOSIS:  
 This is an inherited autosomal dominant condition. Mostly seen in 
white female of forties. Lesions occur over the sun exposed areas and 
more during summer, better during winter. Defective gene is on 
chromosome 12 and 15.Initial lesion will be brownish red / brown conical 
papule, later spreads and ulcerates. Condition worsened by sun light 
exposure. Pathologically malignancy not reported. Treated by 
cryotherapy. 
 
ERYTHROPLASIA OF QUEYRAT: 
 This is the insitu squamous cell carcinoma of Bowen’s disease that 
affects the glans or prepuce of the penis. More common in uncircumcised 
individual of more than 40 years of age. Caused by the HPV variants. 
Clinically the lesions appear as a single or multiple, fixed, well- 
circumscribed reddish plaques. They are erythematous, moist and velvety 
or smooth. The diagnosis is confirmed by biopsy.   
Once the diagnosis is confirmed sex partner(s) of the diseased to be 
evaluated.  Because of the tendency to develop pre invasive or invasive 
carcinoma of cervix or anus.  The progression in to invasive SCC is more 
commoner, more aggressive and early to metastizse than Bowen’s disease 
of non genital skin. 
Differential diagnosis: 
 a) Zoot balanits 
b) Candidiasis 
c) Penile Psoriasis 
d) Paget’s disease 
e) Irritant balanitis. 
 
 
 
TREATMENT: 
1) Topical therapy by using 5% 5FU cream once a day under 
occlusion, 5% Imiquimode cream once daily 3 days in a week for 3 
to 12 weeks will be effective. 
2) Surgical excision, laser and DPT are effective for the lesions not 
cured.  
3) Radiotherapy. 
BOWENOID PAPULOSIS OF THE GENITALIA: 
 This is a localized form of in situ SCC due to high risk HPV 16 and 
18. The lesions clinically appear as benign with histopathological 
malignant features. Treated by excision, cryosurgery, electro coagulation 
and 5 FU topical applications. 
XERODERMA PIGMENTOSUM: 
 This is a rare inherited, autosomal recessive disorder due to deficit 
in repairing the DNA defect caused by UV rays. They are more prone to 
develop multiple cutaneous and internal malignancies at the earliest age 
and lead to death at their earliest 20s. It is very rare in India. 
Characteristically they are photosensitive with the pigmentary changes all 
over the body more over the sun exposed areas of skin.  
 Premature aging of skin is present. They may develop pre-
neoplastic and neoplastic lesions. BCC, SCC and Melanoma are more 
common at the earliest childhood age. 
Pathology: 
 On exposure to UV rays the linkages between the adjoining DNA 
helices with abnormal pyramidine dimmers are formed. By the series of 
enzymes they are normally excised and the continuity of the helices is 
restored. In XP there is defect in this DNA repair.   
Diagnosis: The diagnosis of XP is by the effective clinical examination 
of the patients with the family history of XP. 
Eye examination will reveal: 
•    Clouding of the cornea 
•    Keratitis 
•    Lid tumor 
•    Blepharitis 
Before the child birth: The diagnosis can be made by the following 
procedures: 
• Amniocentesis, 
• Chorionic villous sampling,  
• 
After the child birth: 
• Skin biopsy 
• Skin fibroblast culture.    
TREATMENT:  
1) Protection from sunlight exposure. 
2) Covering with cloths, applying sun screen lotions, etc.     
3) Premalignant lesions may be treated by excision, Cryo surgery, 
Topical 5FU, oral isoretinoin, chemo surgery / intra lesional INF α. 
4) Genetic counseling is important in prevention of XP. 
LEUKOPLAKIA: 
 These are the premalignant lesions usually seen in the mucous 
membranes of mouth, rectum and vulva. These are whitish hyperkeratotic 
patches. Initial hyper keratosis with marked acanthosis followed by 
dyskeratosis further, progress into carcinoma in situ. Biopsy is mandatory 
for all doubtful lesions. 
INTRAEPITHELIAL CARCINOMA OF THE EYELID MARGINS: 
 Due to the occupational exposure to oil and grease. Dysplastic 
changes are noted in biopsy. The lesion invades the cilliary adnexa and 
causes loss of eye lashes and nodularity of the margin. SCC may occur, 
excision is the treatment of choice.        
LEUKO KERATOSIS OF THE LIPS: 
 Known as actinic keratosis. Lower lip mainly affected due to 
prolonged and excessive exposure to solar radiation. Persistent dry 
scaling with tendency to fissure. Atrophic changes also seen. Progression 
into SCC is more common. 
TREATMENT: 
 Surgical excision, Cryo surgery, CO2 laser ablation, Electro surgery 
and topical 5% 5FU application and DPT. 
RADIO DERMATITIS: 
In early radio dermatitis initial erythematous lesion progresses into 
desquamation and pigmentation. In case of higher doses ulceration 
occurs. In later stage atrophy, irregular hyper pigmentation will be seen. 
Telengiectasia, hair loss also occurs. SCC may develop. 
ARSENICAL KERATOSIS: 
This is the premalignant condition caused by chronic exposure to 
arsenic.  Corn-like punctate keratosis mainly affects the palms and soles. 
Initial small enlarge, thicken and enlarge in number. They may extend 
cause involvement of fingers, dorsum of the hands and proximal portion 
of extremities. Eventually leads to SCC. Induration, inflammation and 
ulceration indicate the malignant transformation.  
Pathological feature ranges from benign hyperplasia / dysplasia, 
mild / moderate atypia to frank Bowen’s disease. Differentiated from 
punctate keratosis, which usually appears in younger age.Darier’s disease 
and lichen planus use to have the lesions in other areas too. 
TREATMENT:   
Multiple lesions are difficult to treat. Topical keratolytics, 
oral acetretin may be beneficial. 
CONGENITAL DERMATOSIS: 
This is the cutaneous condition known as congenital erosive and 
vesicular dermatosis. Generalized erosions, vesicles, crusting and “sealed 
skin-like” erythematous areas are the characteristic features. It involves 
75% of the total body surface. 
PAGET’S DISEASE OF SKIN: 
 This condition, which represents the underlying malignancy. 
Lesions are unifocal or multifocal. Areas most commonly involved are 
groin and axilla. 
Clinically and pathologically the findings are similar to that of 
Paget’s disease of breast. Hyperkeratosis, parakeratosis, acanthosis and 
pale vacuolated Pagets cells are seen in supra basilar epithelium. They 
may or may not invade the dermis. Invasive type has high metastatic rate 
with poor prognosis.  
TREATMENT: 
Excision is the choice of treatment, Mohs surgery, cryosurgery, 
laser, radiotherapy, DPT and 5% imiquimode cream also used. 
Recurrence rate is very high. 
TAR KERATOSIS: 
It is a very rare condition of the workers with tar and pitch. There 
are small keratotic plaques with benign acanthoma features. The lesions 
confined to the scrotum are potentially malignant. 
FAMILIAL CANCER SYNDROMES: 
1) Nevoid basal cell carcinoma syndrome. 
2) Follicular atrophoderma and Basal cell carcinoma. 
3) Rombo syndrome. 
4) Self healing epitheliomas. 
5) Muir – Torre syndrome. 
NAEVOID BASAL CELL CARCINOMA SYNDROME (NBCCS) 
BASAL CELL NAEVUS SYNDROME / GORLIN’S SYNDROME: 
 It is an inherited autosomal dominant disorder. Individuals with 
this disorder will develop multiple BCC with various phenotype 
abnormalities. Affected will present with large forehead which is 
characteristic, jaw cysts, rib abnormalities (bifid / splayed), vertebral 
(scoliosis / kyphosis) and other    skeletal abnormalities (spina bifida 
occluta). Associated with palmo-plantar pits. Macrocephaly with intra 
cranial abnormalities namely corpus collosum dysgenesis and 
calcification of falx cerebri are the other features. The NBCCS gene was 
mapped to chromosome 9q22.3-3.1. Clinically, lesions mainly confined 
to upper face (eye lids, nose, and cheek). The neck, trunk and axillae are 
the frequent sites. 
 The skin manifestations are BCCs, skin tags, palmoplantar pits, 
milia and dermal naevi like lesions.  The lesions vary from 1mm -1.5 cm 
in size. Macroscopically the lesion appears as smooth surfaced, rounded, 
elevated papules, more pigmented. The tumors of axillae, neck and 
eyelids may be pedunculated. 
 Other less common associations are syndctyly, shortened 
metacarpals, cleft lip and   palate, mysentric lymph cyst, bicornuate 
uterus, hypo gonadism. Ocular manifestations like dystopia canthorum, 
cataracts, and congenital blindness.  
    Variety of CNS disorders may develop. Apart from BCCs they are 
more susceptible for rabhdomyosarcoma, ovarian and cardiac fibroma, 
medulloblastoma. Pathologically, they mimic BCCs. Deeper penetration,  
ulceration and invasion with lymphocytic infiltration may occur. 
TREATMENT: 
 Excision is the choice of treatment for all the possible cases. 
Radiotherapy is contraindicated for the acceleration of new BCCs. 
FOLLICULAR ATRPHODERMA AND BASAL CELL 
CARCINOMA: 
 It is a rare genodermatosis, known as Bazex’s syndrome which 
produces multiple BCCs. 
ROMBO SYNDROME: This rare autosomal dominant syndrome is 
charecterised, along with BCCs, vermiculate atrophodermia, milia, 
trichoepithelioma, and hypotrichiosis with peripheral vasodilatation 
SELF HEALING EPITHELIOMAS (Multiple self healing 
epithelioma of Ferguson - Smith):  
 An autosomal dominant disorder, with intermittent development of 
skin tumors which regress spontaneously. Histopathologically identical 
with well differentiated SCC. 
MUIR-TORRE SYNDROME: 
 This is an autosomal dominant disorder, characterized by the 
presence of sebaceous neoplasms with internal malignancies. Mostly 
associated with colonic carcinoma. Sometimes also associated with SCC, 
BCC, Keratoachanthoma and Actinic Keratosis. 
PREMALIGNANT CONDITIONS OF MELANOMA: 
1) Dysplastic naevus syndrome 
2) Junctional naevus  
3) Axial Giant congenital naevi 
4) Blue Naevus 
 5) Hutchinson’s freckling 
DYSPLASTIC NAEVUS SYNDROME (ATYPICAL MOLE 
SYNDROME): 
 The naveus are large in numbers and larger in size. They are 
irregular in size and margins with brownish pigment. They present 
anywhere in the body surface. About 10% may turn into less invasive 
melanoma. Pathologically Excessive mitosis, multiple active Junctional 
naevi with cytological atypia is seen. 
JUNCTIONAL NAEVUS (DERMO - EPIDERMAL NAEVUS / 
MARGINAL NAEVUS): 
 It is a pigmented or cellular naevus with Junctional activity. May 
be single or multiple seen over the extensor aspects of extremities and the 
ventral aspect of genitalia. They appear as flat, smooth and hairless mole. 
Dark-brown or brown in colour. The clusters of cells in basal and prickle 
layer are enlarged and loosely attached with other cells. The nuclei of 
Junctional naevi show atypia with mitosis. Compound naevus may turn 
into malignant very rarely. 
AXIAL GIANT CONGENITAL NAVEUS (GARMENT or 
BATHING TRUNK NAEVUS): 
 Mostly seen over the lower back and back of thighs. Large 
numbers of small congenital naevi also will be there. As the infant grows, 
the involved areas will become thicker and darker. The surface becomes 
rough and warty nodular lesions will appear. As the age advances hairy 
component will be more.  They usually associated with spinabifida, 
meningocele and club foot. Von Recklinghausen’s disease, vascular naevi 
also the associated conditions. 
BLUE NAEVUS: 
 It’s a rare benign tumor considered as a premalignant, rarely 
become malignant. Excision is the treatment of choice.   
TREATMENT:  
Prophylactic surgical excision should be done before the age of 
five because of their malignant potential. In deep shave procedure  
recurrence will be more.         
                   
CLASSIFICATION 
BENIGN EPIDERMAL TUMORS: 
1) Seborrhoeic Keratosis 
2) Stucco Keratosis 
3) Skin tags 
4) Dermatitis Papulosa nigra 
5) Haber’s syndrome 
6) Melanoacanthoma 
7) Keratoacanthoma 
8) Clear cell acanthoma 
9)  Generalized eruptive Keratoacanthoma 
10) Pseudo epitheliomatous hyperplasia 
CYSTS OF SKIN: 
1) Epidermal cyst 
2) Trichilemmal cyst 
3) Milium 
4) Steatocystoma multiplex 
5) Premalignant fibro epithelial tumor of pinkus.   
BENIGN TUMORS OF THE SKIN APPENDAGES 
Hair Follicle Tumors: 
• Inverted follicular keratosis 
• Follicular infundibulam tumors 
• Pilar sheath acanthoma 
• Trichoadenoma 
• Comedo naevus 
External Root Sheath Tumor: 
• Trichilemmoma 
• Trichillemal cyst 
• Proliferating trichilemmal tumor 
Hamartomas and hair germ tumors and cysts: 
• Tricho blastoma 
• Hair follicle naevus 
• Tricho folliculoma 
• Tricho epithelioma  
• Dermoplastic Trichoepithelioma 
• Solitary cyst Trichoepithelioma 
• Eruptive villous cyst 
• Cutaneous lymphadema 
• Basiloid follicular hamartoma 
Hair Matrix Tumor: 
• Pilomatrixoma 
Hair Follicle Mesenchymal Tumor: 
• Trichdiscoma 
• Perifollicular fibroma 
• Fibro folliculoma 
Sebaceous Gland Tumors: 
• Sebaceous adenomas and sebaceomas 
• Superficial epithelioma with sebaceous differentiation 
 
Apocrine Gland Tumor: 
• Apocrine hidrocystoma 
• Apocrine tubular adenoma 
• Syringocystadenoma paailliferum 
• Hydradenoma papilliferum 
Eccrine Gland Tumors: 
• Eccrine hidrocystoma 
• Hidroacanthoma simplex 
• Eccrine poroma 
• Eccrine dermal duct tumor 
• Eccrine syringe fibradenoma 
• Syringoma 
• Papillary Eccrine adenoma 
Eccrine or Apocrine / Follicular Tumors: 
• Hidradenoma 
• Cylindroma 
• Spiradenoma 
• Mixed tumor of the skin. 
Malignant Skin Conditions: Classified as,  
• Epidermal 
• Dermal 
• Skin appendage tumors 
• Metastatic tumors. 
Epidermal Malignancies: 
Non Melanoma Skin Cancers: 
• Basal cell carcinoma (BCC) 
• Basosquamous carcinoma (BSC) / Metatypical Basal cell carcinoma 
• Squamous cell carcinoma (SCC)  
• Malignant Melanoma / Melano carcinoma  
 
DERMAL MALIGNANCIES: 
Fibrous Tissue Tumor: 
• Dermatofibro sarcoma protubrens 
Tumors of Blood Vessels: 
• Angiosarcoma, 
• Hemangiopericytoma 
• Kaposi’s sarcoma 
Tumors of Nerve: 
• Neurofibro sarcoma 
Others: 
• Lymphoma  
Appandage Malignancies: 
• Trichilemmal carcinoma 
• Pilomatri carcinoma 
• Sebaceous carcinoma  
• Sweat gland carcinoma 
o Ductal 
o Apocrine 
o Follicular carcinoma 
Eccrine Gland Carcinoma: 
• Malignant eccrine poroma 
• Aggressive digital papillary adenoma 
Eccrine or Apocrine /Follicular Carcinoma 
• Malignant Cylindroma 
• Malignant Hidradenoma 
• Malignant Spiradenoma 
• Microcystic adnexal carcinoma 
• Eccrine epithelioma 
• Mucinous carcinoma and Adenoid cystic carcinoma 
Miscellaneous: 
• Tumors of anogenital mammary like glands 
• Paget’s disease of the nipple 
• Extra mammary Paget’s disease 
• Lymphoepithelioma like carcinoma 
• Merkle cell carcinoma. 
Metastatic Tumors: 
  From Breast, Lungs, Stomach, Colon, Kidney, Uterus, Ovary and 
Prostate.                                
CLINICAL FEATURES AND HISTOPATHOLGY 
BASAL CELL CARCINOMA (BCC) 
Synonyms:  Rodent ulcer, Basilioma, Basal cell epithelioma. 
Definition: 
 It is a locally invasive, most common type of malignant skin tumor 
which arises  from basal layer of the epidermis. These are the slow 
growing which rarely metastaize. BCC is more common in males than 
females.  
Histiogenisis: 
The tumor arises from the pluripotentiality of immature cells of the 
epidermis. They mature towards any of the epithelial structure which is 
governed by the connective tissue in its proximity. 
Clinical Features: 
Early tumors presents as a nodule in the substance of skin. They 
appear small translucent / pearly, raised and rounded areas. Few 
telengiectatic vessels run over the surface, seen in cystic type. Advanced 
tumors have various forms with initial nodular appearance. Ulceration 
occurs at the latter stage. The surface becomes irregular as the tumor 
grows. In case of superficial spread the tumor will have thread-like raised 
margin with irregular border. 
In atypical rodent ulcer, the edge and base are indurated. Edges of 
the tumor are raised. In the areas like nasolabial fold the edges are flushed 
with the surface. Floor of the ulcer is below the level of the surface and 
appears fleshy with poor vascularity. Surrounding area is inflamed. The 
ulcer spreads deeper and destructive in nature commonly in the areas of 
eye, nose and ears. 
In more advanced cases the lesion erodes the periorbital tissues, 
facial, skull bones, and up to the meninges, termed as ULCUS 
TEREBRANS (penetrating ulcers). 
Clinical and pathological Types:  
• Nodular 
• Superficial spreading 
• Micronodular 
• Infiltrative 
• Pigmented 
• Morpheaform / Sclerosing  
• Basosquamous / Metatypical / Transitional carcinoma. 
• Granular cell, clear cell types  
• Alveolar / cystic  
• Adenoid  
• Keratotic  
• Fibro epithelial tumor (of pinkus) 
NODULOCYSTIC / NODULOULCERATIVE:  
 The commonest type of BCC. 70 % of BCCs are nodulocystic or 
noduloulcerative type. The solitary, nodular lesion appears over the skin 
remains static for years and ulcerates. Often they have telengiectatic 
vessels over the surface. The ulcerative type is known as rodent ulcer. 
SUPERFICIAL SPREADING: 
These are the red, scaling lesions mainly over the trunk. Slow 
growing and rarely metastasize. 
MORPHEAFORM:  
These are the whitish flat, plaque like lesions. Aggressive in nature. 
Should be treated promptly. 
PIGMENTED: 
Darkly pigmented, nodulocystic lesion. To be differentiated from 
malignant melanoma.  
BASOSQUAMOUS CARCINOMA: 
This is the rare variant of BCC, accounts 3%. They contains 
features of both SCC and BCC. Regional lymphadenopathy is more 
common. Distant metastasis and recurrence rate is high. To be treated 
aggressively with adequate marginal clearance. 
 
Anatomical sites: 
The lesions are usually may be multiple and arise mainly from 
head and neck. Moreover the upper central part of the face.  
Morphoeic form   - Face ,  
Superficial spreading – Trunk.  
Rarely the palms and soles are affected. 
Pathology: 
 The clumps of cells presented in the connective tissue stroma. They 
are uniform in size and ovoid. The nuclei are dark with scanty cytoplasm. 
The cell nests are lined by a single layer of columnar with palisade 
arrangement. The tumor cells are surrounded by the lymphocytes. In the 
early lesions tumor cell nests can be seen arising from the epidermis. As 
the tumor grows extension into the dermis is noted. 
Treatment: 
         Surgical excision with adequate clearance. 
  
SQUAMOUS CELL CARCINOMA (SCC) 
Synonyms:  Epidermoid carcinoma, Epithelioma. 
Definition: 
It is the more common cancer in whites. Also occurs in non-whites 
with anatomically different presentation. 
The malignant tumor that arises from the epidermal keratinocytes. 
Less common and more invasive than BCC. Having increased tendency 
to metastazise. It occurs as a single lesion in a normal skin and multifocal 
lesion in abnormal skin. Solitary lesion grows more rapidly, infiltrates 
wider and deeper than BCC. 
Pathology: 
SCC is originated from epidermal keratinocytes. SCC begins when 
the atypical Malphagian cells break through the basement membrane and 
invade the dermis.    
These expand into bulb like masses. In due course of time, the cells 
nearest to the centre undergo degenerative changes and keratin mass is 
formed. The central keratinization surrounded by the malignant squamous 
cell is called “CELL NEST” or “EPITHELIAL PEARL” is the 
characteristic of well differentiated SCC.  About 80% of SCC is 
extremely well differentiated. The cells are large and polygonal in shape, 
with abundant cytoplasm, vesicular nuclei and prominent nucleoli. 
Intercellular bridges are well developed.  
Poorly differentiated SCC:    
Anaplastic cells with basophilic cytoplasm. There is no cytological 
evidence of origin.   
BRODER’S CLASSIFICATION:  
By the differentiation (degree of keratinization). 
Grade I  :   <25 % Undifferentiated tumor cells. 
Grade II :  25 to 50 % Undifferentiated tumor cells. 
Grade III :  50 to 75 % Undifferentiated tumor cells.  
Grade IV :  > 75 % Undifferentiated tumor cells. 
Clinical Features: 
SCC usually arises from the traumatized skin. The skin damages 
are elastosis; keratosis, irregular pigmentation and telengiectasia are 
caused by the sun light. Induration is the first clinical sign of malignancy. 
The lesion initially starts as a warty nodule and ulcerates soon. There are 
two types of growth patterns.  
Infiltrative type - The ulcer with edge everted and spreads well beyond 
the ulcer. 
Exuberant type - The growth produces cauliflower like ulcerating mass 
with minimal infiltration around the base.                                   
Clinical and pathological types: 
SPINDLE CELL SCC: Continuity of tumor cells with basal layer of the   
epidermis, foci of clear cut squamous change and immunoreactivity all 
are diagnostic of SCC. 
ADENOID / PSEUDO GLANDULAR:   
It occurs in the sun exposed areas mainly due to solar keratosis. 
Lack of cohesiveness (acantholysis) is the responsible factor. 
VERRUCOUS CARCINOMA / EPITHELIOMA CUNICULATUM:  
These are ulcerated, fungating polypoid mass. Commonly appears 
over the sole of foot. Marked acanthosis and papillomatosis are the 
features. This is locally potent malignant tumor, Prognosis is good.      
Clinical Types of SCC: 
• Proliferative type 
• Ulcerative type 
• Verrucous type 
• Plaque type 
• Fissure type (lips and genitalia).      
 
SCC may present as: 
• A slow growing, locally invasive lesion with late metastasis ( from 
solar keratosis) 
• Rapidly growing, early metastatic lesion. 
SCC from Bowen’s disease, chronic ulcers and scars, chronic 
radiation dermatitis, from normal looking skin, genitalia and anal region 
are more  aggressive.  
Anatomical sites: 
Lower extremities and loin are common sites in India. Sun exposed 
areas – back of hands, fore arm, upper part of the face. Lower lip and 
pinna are the more common sites in males. 
Recurrence rate is high in case of SCC more than 4mm 
thickness. 
Metastasis is inevitable when the lesion is 10 mm or more in 
diameter. 
  
American Joint Committee on Cancer system (AJCC) for  
classification and staging of carcinoma of skin (2002) 
Primary tumor (T) 
Tx  -Primary tumor cannot be assessed 
To  - No evidence of primary tumor 
Tis  - Carcinoma insitu 
T1  - Tumor ≤ 2cm 
T2  - Tumor 2.1 – 5 cm 
T3  - Tumor ≥ 5cm 
T4  - Tumor invasion deep extra dermal structures  
         (cartilage ,muscle / bone) 
Regional  Lymph Nodes (N) 
Nx  - Regional lymph nodes cannot be assessed 
No  - No regional lymph node metastasis 
N3  - Regional lymph node metastasis. 
Distant  Metastasis: 
Mx  - Distant metastasis cannot be assessed 
Mo  -No distant metastasis 
M1  - Distant metastasis 
STAGES 
       Stage 0 Tis , No, Mo 
      Stage I  T1, No, Mo 
       Stage II T2-3, No, Mo 
       Stage III T4, No, Mo or any T, N ,Mo 
       Stage IV Any T any N, M 
 
MELANOMA 
Definition:  
It is a potent malignant skin tumor that originates from the 
melanocytes of dermoepidermal junction. It is a more invasive and 
metastatic tumor. Invasion occurs both the horizontal and vertical 
directions. 
Pathology: 
The presence of cytologically malignant melanocytes with invasion 
into dermis, areas of in situ malignant change in adjacent epidermis is the 
diagnostic features of superficial spreading melanoma. 
The cells are with abundant acidophilic, fine granular cytoplasm.  
Pseudo nuclear inclusions, epithelial and spindle cell patterns of growth 
are the other features. The radial growth phase of intraepidermal 
melanocytes occurs before the dermal invasion. 
Pathological staging: 1. CLARK’S level of invasion: 
Level 1: Lesion confined to epidermis (insitu); rarely metastasizes; Cure 
rate is 100 %.                 
Level 2 : Invasion into papillary dermis, past basement 
membrane(localized).  
Level 3 : Tumor filling papillary dermis (localized) and comprising the 
reticular dermis.  
Level 4 : Tumor invasion of reticular dermis (localized). 
Level 5 : Tumor invasion of subcutaneous tissue (direct extension). 
2. Thickness of the tumor: 
Measured by optical micrometer, BRESLOW’S tumor thickness and 
prognosis: 
Tumor thickness 5 year Survival rate 
<1mm 95-100% 
1- 2mm 80-96% 
2.1 –4mm 60-75% 
>4mm 50% 
Clinical Staging: 
                        Stage                     Description 
I Cutaneous  lesion defined 
IIa Satellite nodules / transit metastasis 
IIb Regional nodal involvement 
IIab Both satellite and regional nodal 
involvement 
III Widespread metastasis 
 
Clinical features : Features suggestive of benign naevus turning into 
malignant are ABCDE. 
A - Asymmetry 
B - Border irregularity 
C-Colour variation 
D- Diameter more than 6mm 
E- Elevation 
Types: 
1)  Superficial spreading 
2)  Nodular 
3)  Acral Lentigenous 
4)  Lentigo maligna 
5) Amelanotic 
SUPERFICIAL SPREADING MELANOMA: 
 Common in 4th / 5th decade. Trunk (in male) and leg (in female) 
are the common sites. Head, neck and foot are the less common sites. 
Colour of the lesion varies (brown / black / red /grey and white), irregular 
edges are the diagnostic features.  
Notching of the margin, peripheral extension also seen. Red colour 
indicates inflammation / neo vascularisation. Regressing lesions are white 
-grey in colour. Duration of the lesion varies from few months to many 
years. 
NODULAR MELANOMA : 
It is an aggressive lesion, occurs more in male than female, during 
5th / 6th decade. They are elevated polypoid dome shaped or pedunculated 
lesions. Trunk is the more common site.  Develops from the pre existing 
mole, enlarges rapidly and become palpable, firm nodule. Colour varies 
(dense black/reddish blue black). Ulceration and bleeding occurs 
frequently. 
ACRAL LENTIGENOUS MELANOMA: 
This is the commonest type and known as palmo plantar 
melanoma. Commonly seen over the palms, soles and sub-ungual regions.  
More common in darks than whites. Sub-ungual lesions appear as blue 
black discoloration of the posterior nail  fold commonly thumb / big toe. 
LENTIGO MALIGNA MELANOMA: 
The least malignant form. The commonest sites are upper cheek, 
forehead and  temple areas. Arm, hand and leg are the other less common 
sites. Initial lesion appears as flat, brown macule. Pigmented irregularly 
with areas of advancing and regressing. Colour may vary from brown to 
tanned black. Increase in tumor thickness and nodularity indicates 
malignant change. 
AMELANOTIC MELANOMA: 
This is the condition usually present with nodal metastases. Lesion 
is pink in colour usually contains pigmentation at the base. Positive 
DOPA reaction is helpful for diagnosing. 
MUCOSAL MELANOMA: 
This is a rare condition, seen over the mucosa of oral cavity, 
genitalia and anal region. Presence of excessive, irregular, macular 
pigmentation are the characteristic. Genital lesions are rare variant occurs 
in 7th decade. 
SECONDARY MELANOMA WITH UNKNOWN PRIMARY: 
The sites are regional lymph nodes. They are isolated, non 
pigmented sub cutaneous nodules, with occult primary. Ocular and 
mucosal primary lesions to be  ruled out. Spontaneous resolution of the 
primary lesion may be other reason which may be indicated by the 
depigmented area.  
MULTIPLE PRIMARY MALIGNANT MELANOMAS: 
More common in patients with atypical mole syndrome. Primaries 
may be in various anatomical sites. The second and other tumor lesions 
may be metastasis from the primary lesion. 
 
 
 
 
 
 
 
 
American Joint Committee on Cancer system TNM Melanoma 
classification (2002) 
Primary Tumor (T) 
Tx – Primary tumor cannot be assessed 
To – No evidence of primary tumor 
Tis – Melanoma insitu 
T1 – Melanoma ≤ 1mm in thickness with or without ulceration 
T1a – Melanoma ≤ 1mm in thickness and level II or III, no ulceration 
T1b – Melanoma ≤ 1 mm in thickness and level IV or V with ulceration 
T2  - Melanoma 1.01 – 2 mm in thickness with or without ulceration 
T2a – Melanoma 1.01 – 2 mm in thickness , no ulceration 
T2b – Melanoma 1.01 – 2 mm in thickness with ulceration 
T3 – Melanoma 2.01 -  4 mm in thickness with or without ulceration 
T3a – Melanoma 2.01 – 4 mm in thickness , no ulceration 
T3b – Melanoma 2.01 – 4 mm in thickness with ulceration 
T4 – Melanoma  > 4mm in thickness with or without ulceration 
T4a – Melanoma > 4mm in thickness, no ulceration 
T4b – Melanoma > 4mm in thickness with ulceration 
 
 
Regional Lymph Nodes (N) 
Nx – Regional cannot be assessed 
No – No regional lymph node metastasis 
N1 – Metastasis in one lymph node 
N1a – Clinically occult (microscopic) metastasis 
N1b – Clinically apparent (macroscopic) metastasis 
N2- Metastasis in 2 or 3 regional lymph nodes or intra lymphatic regional    
        metastasis without nodal metastasis 
N2a – Clinically occult (microscopic) metastasis 
N2b – Clinically apparent (macroscopic) metastasis 
N2c – Satellite or in transit metastasis without nodal metastasis 
N3 – Metastasis in 4 or more regional nodes, matted metastatic nodes, in-
transit  metastasis or satellites with metastasis in regional node /nodes. 
 Distant Metastasis (M) 
Mx – Distant metastasis cannot be assessed 
Mo – No distant metastasis 
M1 – Distant metastasis 
M1a – Metastasis to skin sub cutaneous tissue or distant lymph nodes 
M1b – Metastasis to lungs 
M1c – Metastasis to all other visceral sites or distant metastasis at any   
            site associated with elevated LDH 
  
 
American Joint Committee on Cancer Melanoma stage classification 
            Pathological stage                       Grouping 
Stage 0 
Stage I A  
Stage IB 
Stage II A 
Stage II B  
Stage II C 
Stage III A 
 
Stage III B 
 
 
 
 
Stage IIIC  
 
 
Stage IV 
Tis  No Mo 
T1a No Mo 
T1b-2a No Mo 
T2b – 3a No Mo 
T3b – 4a No Mo 
T4b     No Mo 
T1 4a   N1a Mo 
T1 4a   N2c Mo 
T1 4b N1a Mo 
T14b N2a Mo 
T1 4a N1b Mo 
T14a N2b Mo 
T1 4a/b N2c Mo 
T14b N1b Mo 
T14b N2b Mo 
Any T N3 Mo 
Any T Any N M1 
 
 
PROGNOSTIC INDICATORS: 
Good prognosis: 
• Women. 
• A large infiltrative infiltrate. 
• Nodular, superficial spreading, Lentigo maligna. 
Bad prognosis: Thickness of tumor > 3mm.Regional lymph node 
metastasis. 
Poor prognosis: Lesions over the trunk, head and neck, palmo – plantar,  
subungual areas and BANS (superior aspect of back and posterior aspect 
of arm, neck and scalp) area.  
Presence of ulcers and old age. 
Grave prognosis: Distant metastasis 
DERMAL MALIGNANCIES: 
MERKEL CELL CARCINOMA (MCC): 
 It is a rare aggressive tumor arising from the cutaneous Merkle cell 
– neuro endocrine cell. More common in female. PUVA therapy is the 
high risk for the development of MCC. Immuno suppression, HIV 
infection, double stranded DNA viruses, polyoma viruses are the other 
pathogenic factors. Common sites are head, face (38%), extremities and 
trunk. Clinically the lesions are rapidly growing, firm, flesh colored / red 
violaceous, dome shaped papule / plaque. Regional lymph node and 
distant metastasis is more common. 
Histological features: 
 Resemble small lymphocytes or poorly differentiated metastatic 
deposits. The cells are argyrophillic with scanty cytoplasm. The nuclei 
are round / oval with 2-3 nucleoli.  Intermediate, small cell and trabecular 
are the sub types. 
Treatment: 
Excision with prophylactic lymph node dissection followed by RT. 
Tumor responds well to RT. 
EPITHELIAL MALIGNANCIES: 
 These are the rare skin appendage tumors arising from the eccrine 
sweat glands, the hair follicles, the sebaceous glands and the apocrine 
glands. 
CLASSICAL SWEAT GLAND CARCINOMA: 
 The tumor arises from eccrine or apocrine sweat glands. Painful 
reddish nodules of scalp and face are seen. Treatment is wide excision 
with regional lymph node block dissection.    
MICROCYSTIC ADNEXAL CARCINOMA / SCLEROSING 
SWEAT DUCT CARCINOMA: 
It is a slow growing tumor. Appears as an indurated plaque. Seen 
over the central area of the face. Cytologically cords of atypical basal 
keratinocytes with ductal differentiation in a sclerotic stroma are seen. 
Treatment is microscopic surgical excision can be done because of 
perineural invasion.   
BASAL CELL CARCINOMA OF ECCRINE GLANDS ( ECCRINE 
EPITHELIOMA): Seen over the scalp. Treatment: Wide local 
excision. 
MUCINOUS ECCRINE CARCINOMA: 
It arises from head and neck area. Mostly from periorbital region.  
Histopathology :  Central pale cells are surrounded by dark staining cell 
in a palisading manner. They are separated by broad fibrous septa. 
Treatment: Wide local excision. 
ADENOID CYSTIC CARCINOMA: 
 It may be metastatic tumor of salivary gland. Appear as painful 
nodules over the head and neck. Basophilic cells with a distinct adenoid / 
cribriform pattern is seen. 
Treatment: Wide local excision. 
KAPOSI’S SCARCOMA (KS): 
The tumor is seen in the immunosuppressive and AIDS patients. 
They arise spontaneously primarily over extremities and also anywhere 
on the skin and viscera. They present as rubbery bluish nodules. They are 
multifocal lesions rather than metastatic. Early lesions may resemble 
hemangiomas and the older will be like sarcomas. The lesions are locally 
aggressive with periods of remission. The nodal spread is very rapid and 
also to the GI, respiratory tract which carries poor prognosis. 
Nodular type: It is a least lethal type. Occurs on the lower extremities 
mainly over legs and feet as bluish red raised nodules. Odema and 
pigmentation is seen. 
Florid type    :  Ulcerative. 
Infiltrating type: Infiltrates deeply under lying structures.                   
Histopathology:  
 Less malignant form reveals irregular vascular sinuses with 
intervening stroma that contains macrophages with haemosiderin. The 
endothelial cells the lining vascular sinuses may infiltrate into adjacent 
collagen bundles. The cells are with little mitosis and anaplasia.  
Potentially malignant form has spindle cells with formation of abnormal 
vascular slits.                   
Treatment: 
 Both radiotherapy and chemotherapy (intra lesional / intra venous 
vinblastin) are effective in control of disease. Immunomodulators are 
useful. Monoclonal antibodies are useful in AIDS patients.  
 
ANGIOSARCOMA: 
The tumor arises spontaneously. Scalp, face and neck are the 
commonest sites. They appear as a bruise which spontaneously bleeds or 
enlarges without any trauma. They also may arise from the prior 
radiotherapy areas or in the setting of chronic lymphadema of the arm, 
usually after the mastectomy (Stewart-Treves Syndrome).Anaplastic 
endothelial cells surrounding vascular channels are seen. Total excision 
of the early lesion occasionally cures the condition. Prognosis is usually 
poor. Only less than 20% will have 5- year survival. Chemotherapy and 
radiotherapy are used for palliative treatment. 
DERMATOFIBROSARCOMA PROTUBERANS: 
This is the soft tissue sarcoma arises from the fibroblasts, 
commonly occurs in 2nd –5th decade males. Trunk (50-60%), proximal 
extremities (20-30%), head and neck (10-15%) are the common  
locations. This is a slow growing and locally invasive tumor. The lesion 
may appear as single or multiple nodules, pink in colour. They often 
ulcerate and infected. With enlargement it becomes painful. 
Atypical spindle cells, located around a core of collagen tissue. 
Treatment:  
 Wide local excision is the treatment of choice. Recurrence and 
mortality due to metastasis is high. Three dimensional excisions with 2 to 
3 cm margin are advocated. Because of the radio sensitivity, surgery 
combined with radiotherapy provides 95% of 10 year survival. 
Chemotherapy with Imatinib also useful. 
FIBROSARCOMA:   
  These are the hard, irregular masses found in the 
subcutaneous fat. Markedly anaplastic fibro blasts with disorganized 
growth. Treatment is wide local excision. 5 year survival is about 60%. 
Recurrence is high due to incomplete excision. 
LIPOSARCOMA:   Usually arises in the deep muscle planes, rarely 
from sub cutaneous tissues. Common site is thigh. Treatment is wide 
local excision.  Radiotherapy for metastatic disease. 
PRIMARY CUTANEOUS MALIGNANT LYMPHOMA: 
• Mycosis fungoides 
• Seszary syndrome 
• Primary cutaneous Hodgkin’s lymphoma, B- cell lymphoma 
• Worringer – kollop disease. 
MYCOSIS FUNGOIDES: 
 This condition is charecterised by primary infiltration of the skin 
by malignant lymphocytes followed by systemic involvement. Commonly 
seen in 4th -6th decade.  
Presents with long standing dermatitis, exfoliative erythroderma or 
a popular rash which latter progress into plaque and tumor formation.  
SEZARY SYNDROME: 
 It appears as an erythroderma with intense erythematous colour. 
Thickening of face, neck and palms are the associated features. Abnormal 
mononuclear cells are seen in peripheral smear. These are large cells with 
dense reniform nucleus. Diagnosed by histopathology and DNA flow 
cytometry. Radiotherapy is the treatment of choice for localized, B cell 
lymphomas. Chemotherapy and radiotherapy is useful for other lesions. 
Electron beam therapy is used for mycosis fungoides. 
METASTATIC MALIGNANT SKIN TUMORS: 
 These are the tumors due to the deposition of the malignant cells 
from various  sites via blood or lymphatic circulation. More common 
primary sites are breast, stomach, lung , large intestine, uterus, ovary, 
kidney, prostate, liver and bone. Hypernephroma accounts for about 9% 
of skin metastasis. 
 
 
 
DIAGNOSIS 
Diagnostic tools for skin malignancies: 
1) History and clinical examination 
2) Biopsy and histopathological examination 
3) Chest X ray, Ultrasound and CT scan - for metastatic work up. 
Types of biopsy: 
1) Aspiration needle biopsy 
2) Wedge biopsy 
3) Excisional biopsy (done for tumor size < 1.5 cm diameter) 
4) Incisional biopsy 
5) Electro coagulation and shave biopsy 
6) Frozen section 
Aspiration needle biopsy:    Depends upon the skill of the pathologist. 
Fear of the tumor implantation along the needle tract is the disadvantage. 
Frozen section: This procedure is not only useful for intra operative 
diagnosis, but also to provide adequate tumor clearance.   
          
 
DIFFERENTIAL DIAGNOSIS 
So many conditions that can mimic skin cancers, they should be 
differentiated by clinical and  histopatholical means carefully. 
Basal Cell Carcinoma (BCC): 
SCC, Dermal naevus, scar, Seborrhoeic keratosis, nodular, 
superficial spreading and lentigo melanoma, adnexal tumors of the skin, 
adenoid cystic carcinoma etc 
Squamous Cell Carcinoma (SCC): 
Keratoacanthoma         -  slow growing with dome shape. 
Basal cell carcinoma         -  No lymph node enlargement, no 
induration at the base. Edges of the ulcer 
is raised and beaded. 
Warty horns                   - Usually multiple and not indurated. 
Malignant Melanoma (MM): 
Melanocytic naevus   -  less variegated 
Pigmented BCC              - Rolled out and beaded edge 
Histiocytoma (Sclerosing   - It is firm and rubbery. Yellowish brown  
                          angioma)   in colour Thrombosed vascular.  
Malformation        -  Pre existing lesion will be there. 
Pigmented senile wart      -  It is a scaly lesion.  
Sub ungual hematoma  and Pyogenic granuloma. 
TREATMENT 
TREATMENT OF SKIN CANCERS 
Goals of the treatment: 
1)  To cure the disease. 
2)  To preserve the cosmesis and function. 
TREATMENT MODALITIES: 
1)  Surgery 
2) Radiotherapy 
3) Curettage and electro desiccation 
4) Cryotherapy 
5)  Chemosurgery 
6)  Laser   
7) Immunotherapy 
8) Photodynamic therapy 
9) Topical and oral agents 
10)  Recombinant gene products    
 In spite of all treatment modalities mentioned some tumors are 
difficult to treat due to their anatomical location, histological type, sub 
clinical extension and recurrence. 
SURGERY: (WIDE LOCAL EXCISION) 
          Surgery is the best treatment for all operable skin malignancies to 
provide cure from the disease, good cosmetic and functional restoration. 
Excision is performed by eliptical incision which helps for the primary 
closure of the wound with good cosmetic results. Surgical margins vary 
according to the type of tumor. 
Basal cell carcinoma: 0.5 – 1.0 cm margins for all types is adequate. 
Squamous cell carcinoma: 1cm margins are mandatory, may be 
combined with lymph node dissection if necessary. 
Melanoma:  Lesions with 1mm thick 1cm margin, for 2-4mm thickness 
2cm margin and more than 4mm thickness 3cm margins are 
recommended. This should be combined with sentinel LN biopsy                  
(1-4 mm thickness with occult LN), elective / prophylactic LN dissection 
(1-4 mm thickness). LN dissection can be ilio-inguinal, axillary 
dissection (nodes medial to the pectoralis minor also removed), 
superficial parotidectomy with radical neck dissection – for face, 
anterior scalp and ear lesions to be done. 
Sub ungual malignant melanoma- amputation at distal IP joint / ray 
amputation done for finger and thumb primary. 
SURGERIES FOR DISTANT METASTATIC DISEASE: 
• For local recurrence (lesions with in 5 cm of) – wide excision with 
3-5 cm margin.  
• For in transit nodules – complete excision with CT.  
• For bulky and diffuse recurrence – partial amputation.  
• For solitary lung metastasis – chemotherapy and surgical removal. 
Pathological fractures – external / internal fixation with CT/ RT. 
• GIT metastasis – bleeding, perforation, intussusceptions - surgery.            
Unilateral adrenal metastasis–adrenelectomy. Solitary brain 
metastasis–surgical extripation followed by whole brain irradiation 
and CT. 
MOH’S MICROSCOPIC SURGERY:  
           Advocated for SCC and BCC. The roll in MM is controversial. 
Serial excision in small increments along with immediate microscopic 
evaluation which ensures the complete tumor removal in aesthetically 
valuable tissues (eyelid, nose, cheek).The procedure can be performed 
under local anesthesia. The removal of normal tissue also very minimal. 
The length of the procedure is the main drawback. Needs multiple           
attempts, several procedures for several days for complete excision.          
Cost, skill of the person also to be considered. 
          Indications in BCC: Tumor location (mask area of face, scalp, 
anatomical fusion planes, periorbital/eyelid), >2cm in size, Morpheaform 
lesion, recurrent tumor, incompletely removed tumor, lesion on prior 
radiated site,  post transplant immunosuppression, to have normal tissue 
for function and  cosmesis, to achieve higher cure, cosmesis, and 
function. 
Indications in SCC: Infiltrative SCC, poorly defined margins, tumor site  
(lips, ear,nailbed,nasal tips, eyelid and genitalia), irradiation site, 
involvement of bone, nerve and muscle, recurrenent large lesion, verrucus 
carcinoma, tumor  from chronic scaring condition. 
Other conditions: Fibrohistiocytic tumors, leiomyosarcoma, liposarcoma 
angiosarcoma, Merkel cell carcinoma are very useful. 
CRYO SURGERY: The destruction of the lesion by using cold 
temperature. Liquid nitrogen is used (-195.5degree C). Procedure is done 
without anesthesia. Less than 2cm lesions can be treated, mainly over 
eyelid, ear, chest, back and tip of the nose. Most of the lesions can be 
excised in one sitting. The entire lesion can be examined by the 
pathologist. Deep infiltrative lesion can be removed completely along  
with the invasive cartilage or bone. Recurrent lesions following RT, 
morphea bcc, BCC lesions from the scar can be treated successfully. 
CURRETAGE AND ELECTRO DESSICATION: 
Used to treat BCC, superficial SCC, precancerous conditions and 
benign lesions. Technique is based on the consistency difference of tumor 
tissue and normal stroma. Meibomian curette is used to eneucleate the 
tumor bulk by curetting followed which stroma and surrounding dermis 
are charred using diathermy / cautery for 1mm depth. Deep infiltrative 
lesion and morphea forms cannot be treated. 
RADIOTHERAPY (RT): 
 Dosage 4000 – 5000 c Gy, in 10 -12 divided doses, for about 2 -3 
weeks.  
Tumors in curved areas radium or radioactive cobalt surface 
mould and for the tumors in mobile areas radium needles or iridium 
wires can be used.  
Electron therapy can be used to treat the lesions of nasal cartilage. 
Indications and advantages:  
         Tumors (BCC, SCC of head and neck, poorly differentiated) 
invading the eyelids, tear ducts and nasal tip without causing destruction, 
where the reconstruction is difficult can be treated with RT. Tumors with 
ill defined margins, to treat the wide margin of   surrounding tissues. 
         Elderly patients with advanced lesions can be treated with less 
trauma than surgery. No need of hospital stay.   
         Radiotherapy in Melanoma-used to treat Lentigo maligna 
(relatively radio sensitive) in elderly infirm patients. 
         Palliative treatment for metastatic disease (brain, bone), also used 
for pain relief, due to secondary bony deposits and pathological fracture. 
Contraindications: Age group less than 40 yrs, previous RT failures, 
radio resistant tumors (Morpheaform BCC). 
Dis-advantages : Scarring, radiation dermatitis, ulceration and malignant 
degeneration are results of improper  RT, radio necrosis due to 
conventional RT, hair loss and baldness. Difficult to execute in areas like 
ear. Requirement of expensive facilities and qualified personals. Long 
period of treatment (4 -6 weeks). 
Interferon α: Used intra lesionally in multiple lesions of old aged frail 
patients. 
IMMUNOTHERAPY: Used only in very few centers for selective 
patients. Principle is by making an individual sensitive to a particular 
antigen which produces delayed hypersensitivity reaction on topical 
application. Used for the large tumor areas not able to treat by surgery 
and other modes. Can be used as prophylactically. Agents used are-
DNCB (Dinitro chlorobenzene), SK (Streptokinase), TEIB (Triethylene 
immuno benzo quinone) and BCG. % 5 FU cream. Smaller lesions can be 
treated earlier with cure rate of about 60 – 90% for BCC. Reduction in 
new tumor formation also achieved. 
HYPERTHERMIC REGIONAL PERFUSION  
(Isolated limbperfusion):   
Indications: Local recurrence, in transit lesions, tumor thickness more 
than 1.75mm without nodal metastasis and Stage II and III disease. 
Melphalan is the drug used for perfusion at more than 40- 41degree C.  
The high local concentration of drug with minimal systemic toxicity is             
achieved. Tumor necrosis factor also used for perfusion. Efficacy is             
improved by in-circuit and heat changer. Myelosupression, vascular              
injury, limb edema and infection are the complications. 
CHEMOTHERAPY (CT): 
No role as adjuvant CT after definitive surgery but for disseminated 
(Stage IV) disease of malignant melanoma. Dacrbazine (DTIC), 
Vindesine are most commonly used drugs. Combination regimens are as 
follows, 
VBM (Vindesine, Bleomycin, Methotrexate),    
BOLD (Bleomycin, Vincristine, Lomustine (ccnu) and Dacrbazine) 
BELD (Bleomycin, Vindesine, CCNU and DTIC) 
CHEMOIMMUNOTHERAPY: 
          Used in stage IV disease of MM.Combination of INF α and 
interleukin 2 with Dartmouth regimen (DBDT) and cisplatin based bio 
CT. 
 Dartmouth regimen-DTIC (Dacrbazine), BCNU (Carmustine), 
DDP  (Cisplatin) and Tamoxifen. 
INTERLEUKINS:  
IL – 2 alone is used to treat metastatic melanoma. In combination 
with lymphokine –activated killer cells more effective. 
MONOCLONAL ANTIBODIES (mAbs): 
 They recognize melanoma associated antigens, like 
peptidoglycans, high molecular weight melanoma-associated antigens, 
glycoproteins, transferring receptor – related antigens  and gangliosides. 
mAbs are used as direct therapeutic agent, along with radioactive isotope 
used for diagnosis of metastasis. Unconjucated murine mAbs having 
clinical response against GD2 and GD3 gangliosides. 
MELANOMA VACCINES: 
 They stimulate immune response against melanoma associated 
antigens. Treating melanoma cells with New castle, vaccina viruses using 
mechanical lysates and immunologic adjuvants like BCG / DETOX. 
Melanoma – deprived peptide antigen vaccines are MART-1, gp -100 and 
the gene therapy, they genetically alter melanoma cells to secrete 
cytokines of interest or increase immunogenicity. Dendritic cell vaccines 
stimulate host anti tumor activity.  
RECURRENCE : 
 This is the major problem which is due to inadequate clearance, 
which fairly depends on the site of the tumor, its type and the treatment 
done already. 
Recurrence after surgery:  
It is due to inadequate marginal clearance. The lesion appear as a 
nodule which develops from the surgical scar. It gradually increases in 
size and reproduces the lesion similar to that of its initial lesion.  
Recurrence after Skin graft or flap cover:  
In this, the lesion appears as nodule beneath the graft. It is very 
difficult to recognize, when the lesion is beneath the flap due to the 
thickness. The graft or flap over the lesion will be mobile for some period 
of time. Failure of normal post operative sequences will be noted in such 
recurrences. 
Recurrence after RT:  
Depends upon the RT dosage administered, the state of the skin 
before  the treatment, the characteristics of the original lesion. Mainly 
seen in excision done on already irradiated skin.  
 
 
BASAL CELL CARCINOMA:   
 The recurrence following secondary treatment of BCC after prior 
surgery or RT is higher than the recurrence after the primary surgical 
treatment. The treatment of recurrent lesions after prior RT is, to include 
possible all adjacent radiographic tissues. Because of the potency to 
change malignant and delayed wound healing of radio atrophic tissues. 
SQUAMOUS CELL CARCINOMA:   
Individual tumors differ from their activity, growth rate etc. The 
lesion may erupt and rapidly reassume the original lesion  or may be slow 
growing in nature. Recurrence after RT appears as  radio necrotic ulcer. 
Biopsy from the margin and base confirms. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Observation  and Results  
 
OBSERVATION AND RESULTS 
 Our study was conducted between September 2011 – November 
2012. Total number of skin malignancies diagnosed was 45 cases. Males 
24 and female patients are 21 in number. Out of them 37 patients are 
from in and around Coimbatore, 5 from Tirupur,1 from Goodalur,  1 from 
Palani and 1 from Dharapuram district. 
 Age of the patients varied from 36 – 85 years. Mostly between 50 – 
70 years. There was no significant family history of skin cancers.  
Total number of newly detected malignancies in CMCH during the study 
period   990(M) +1030 (F)  = 2020 
Skin malignancies newly diagnosed (n): 24(M) +21(F) = 45 
Contributes 2.2 % of overall malignancies in CMCH. 
  
TABLE : 1 
INCIDENCE IN OUR STUDY 
Total cases 45 
Squamous cell carcinoma       31 (69%) 
Basal cell carcinoma               10 (22%) 
Malignant melanoma            04 (9%) 
Others        Nil 
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TABLE : 2 
SQUAMOUS CELL CARCINOMA 
(Sex distribution) 
Sex Total number of cases 31 
Male 19 (61%) 
Female 12 (39%) 
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TABLE : 3 
AGE DISTRIBUTION IN SCC 
Age in years Male Female 
30 – 40 - 1 
41 – 50 5 7 
51 – 60 5 3 
61 -70 7 - 
71 – 80 1 1 
81 -90 1 - 
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Common age group is 40 – 70 years. 
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TABLE : 4 
HISTOLOGICAL TYPE IN SCC  
Type  Male Female 
SCC Proper 12 9 
Verrucous 7 3 
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TABLE : 5 
HISTOLOGICAL GRADE IN SCC  
SCC Grade  No. of Cases Percentage 
Well Differentiated 14 67 
Moderately Differentiate 7 33 
 
CHART : 5 
HISTOLOGICAL GRADE IN SCC  
 
  
MD
33%
WD
67%
ANATOMICAL DISTRIBUTION
Site 
Foot 
Lower limb                                     
Head and neck                                
Upper limb                                     
ANATOMICAL DISTRIBUTION
TYPE OF THE LESION:
Most of the lesions were ulcerative / ulceroproliferative type.     
Two lesions were aroused from the burns scar.
Non healing ulcers after corn shave   
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TABLE : 6 
 OF SCC 
No. of Cases Percentage
17 
11 
3 
- 
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 4 patients had significant palpable lymphadenopathy were 
subjected to fnac.1 patient had metastatic deposit, others had 
reactive adenitis. 
 3patients were treated for leprosy in the past now diagnosed with 
verrucus carcinoma. 
 All the lesions were > 3cms in size 
 One Patient had deformed and ankylosis of the ankle. 
X-rays were taken for all lower limb lesions were normal. CT scan 
for the reliable patients done. There was no abnormality deducted. 
Treatment modalities executed in SCC patients: 
Table – 6a 
SL NO SURGERIES PERFORMED NO OF CASES 
1 Wide local excision with primary 
closure 
4 
2 Wide local excision with SSG 20 
3 Wide local excision with flap cover 2 
4 Below knee amputation 3 
 
 4 patients had lymph node dissection. 
 Two patients were drop out. 
                   
Table -7 
BASAL CELL CARCINOMA 
 
Sl.No SEX  No of Cases Diagnosed 
1 Male 3 (30%) 
2 Female 7 (70%) 
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Table – 8 
AGE DISTRIBUTION IN BCC  
AGE MALE  FEMALE 
30- 40 years  1 
41- 50 years  1 
51- 60 years 1 1 
61- 70 years 2 2 
71- 80 years  2 
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Table – 9 
ANATOMICAL DISTRIBUTION OF  BCC  
SL.NO SITE No. OF CASES 
1 Face 8 (80%) 
2 Lower Limb 1 (10%) 
3 Trunk 1 (10%) 
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  Presentation:  
2 lesions were ulcerative, 2 pigmented and 4 nodular- all were single 
lesion. One patient with Xeroderma Pigmentosum presented with 
multiple    ulcerative lesions over face. 1 lesion Pedunculated type. Size 
of the lesions varies from 1cm -3cm. 
Diagnosis:  
 Clinical & histopathological. 
 7 patients were diagnosed by wedge biopsy and 3 by excision biopsy.  
 X-rays taken to rule out bony erosion.  
Histological types: Among the cases, 
Pigmented BCC- 2 and Basosquamous type- 1. 
 
 
 
 
 
 
Treatment modalities executed in BCC   
Table -10 
Sl No SURGERY NO OF CASES 
1 Wide local excision with primary closure 6 
2 Wide local excision with SSG/ 
flap cover 2 
3 Evisceration and flap cover 1 
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 All patients lesions were excised with adequate margins. 
 1 patient underwent evisceration due to infiltration into orbit. 
 Patient with XP with multiple bcc, 2 off 3 lesions margins were 
positive. One lesion on forehead with features of BCC & SCC. 
Advised 5FU topical application. 
 1 patient with 1 margin positive- on regular follow up at present. 
 All other patients were doing well. 
 1 patient was failed to turn up for treatment. 
67%
22%
11%
Surgeries done in BCC
WLE with Primary closure
WLE with SSG/flap cover
Evisceration with flap cover
Malignant Melanoma (MM) 
 Four patients had diagnosed.  2 male, 2 female. 
Table - 11 
Age  in years Male Female 
30- 40 2 0 
41 – 50 0 1 
51- 60 0 0 
61 – 70 0 0 
71-80 0 1 
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• All the four patients had lesion on the foot. One male patient had 
1x1cm pigmented ulcerative lesion on the plantar aspect of the left 
foot with inguinal node.  
• Another one had ulcerative 2x2cm lesion on left heel.   
Male
50%
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50%
MM Sex incidence
• One female patient had irregular lesion over right great toe. 
Initially   started from a small mole over the pulp of the toe.  
• Another one had lesion over sole of about 3x2 cm. Biopsies taken 
and the diagnosis confirmed and fnac from the node taken. 
Treatment modalities executed: Table – 11a 
Procedure Numbers 
Wide local excision with ilio 
inguinal block dissection 1 
Wide local excision with SSG 1 
Disarticulation of the great toe 1 
 
 
One patient died after the diagnosis due to the age factor and poor 
general condition.  One patient had positive nodal metastasis. Ilio 
inguinal block dissection done for that patient.Postoperatively patient was 
treated with Chemotherapy. Two of the other patients are on follow up.  
 
Most of the patients in our study were in low socio economic 
status. Occupationally manual labours with history of exposure to 
excessive sun light for prolonged period.  17 male patients had history of 
using tobacco products in any form (smoking in 14 patients and tobacco 
chewing in 3 patients). In female 15 of them had the habit of tobacco 
chewing. 1 patient with genetic disorder (XP) with multiple hyper and 
hypo pigmented lesions all over the body and extremities. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
 Discussion 
 Over all incidence of skin cancer is increasing worldwide. In India, 
various studies conducted reveals that the incidence of skin cancers in 
raising trend. The occurrence of skin cancers in India differs from the 
western countries by the anatomical sites. In western countries in US, 
Australia the etiological factors are mainly due to the fair skin, red hair 
phenotype etc. Poor tanning in whites is the important factor that 
contributes increase in incidence of skin cancers in western countries. In 
India even though skin cancers are very low, the incidence is increasing 
in trend. This is because of the various factors like, low socioeconomic 
status of the people, most of them are manual labours, prolonged 
exposure to sun light, smoking and use of of tobacco products. Most of 
the skin cancers occur in the age group of 4th to 6th decade. Males are    
more affected than females. Studies shows there is protective effect from 
skin cancers by NSAIDs. 
Two studies were conducted in CMCH previously. Both the studies were 
conducted for 24 months. Our study period (September 2011- November 
2012). 
 
 
Incidence of skin malignancies: 
Table - 12 
Types of 
malignancy 
Present study 
Total cases 45 
Study I 
Total cases 40 
Study II 
Total cases 54 
SCC 31 (69%) 18 (45%) 33 (61%) 
BCC 10 (22%) 12(30%) 10 (19%) 
MM 04 (09%) 08 (20 %) 09 (17%) 
Others 0 02 (05%) 02 (03%) 
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Sex Incidence: 
Table - 13 
Study Male Female 
Present study 24      (53%) 21 (47%) 
1993 28     (70%) 12  (30%) 
2002 38     (70%) 16 (30%) 
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Table – 13a 
 Type Present study Study I Study II 
M F M F M F 
SCC 19 12   (1.6:1) 13 05   (2.6:1) 27 06   (4.5:1) 
BCC 03 07   (1:2.5) 08 04   (2:1) 06 04   ( 2.5:1) 
MM 02 02    (1:1) 06 02   (3:1) 05 04   (1.25:1) 
Others 00 00 01 01 00 02 
 
On comparisons with the previous studies SCC, BCC having their 
incidence increasing in female population. On the other end melanoma 
cancer incidence is getting down. 
Incidence of skin cancers in India: 
Analysis report of Sv Deo et al, department of surgical oncology 
AIIMS New Delhi.                       Table – 14 
Observation Study of Sv Deo et al Present study 
Incidence of skin cancers 2.4% (77/3154) 2.2% (45/2020) 
Incidence of SCC 55.8% (43/77) 69% (31/45) 
Incidence of BCC 18.1% (14/77) 22% (10/45) 
Incidence of melanoma  26.1% (20/77) 09% (04/45) 
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In India the incidence of skin cancers varying from 0.5 to 2 per 100000   
population. Mean age is 51.8. Report incidence of skin cancers in India is 
< 1.1   of all cancers. Various studies shows increase in incidence of skin 
cancers in  Indians.  
Actual figures of NMSC are not available in most of the region are due to 
poor reported / not reported in many national cancer registry. 
In United States 1.2 million new cases of NMSC are diagnosed / year. 
About  80,000 melanoma are diagnosed / year. BCC is the most common 
malignancy in whites. The incidence in US and Australia are 146 and 726 
/ 100000   population respectively. The annual risk of BCC and SCC in 
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whites of US is   30% and 10 % respectively. Majority of NMSC occurs 
in head and neck   region. Incidence of BCC is high in female. 
Regil et al confined that incidence of SCC about doubled in both genders 
in US population, and Athas wf et al. states that incidence of BCC has 
been increased by 50% in male and 20% in female. Melanoma is the 6th 
leading cancer in US, more common in men than women. Median age 
group of diagnosis is 57 years. Franke et al quotes that the incidence of 
plantar malignant melanoma increased among all other types of 
melanoma. Due to its aggressiveness and late presentation the mortality is 
very high. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of the Study 
 
SUMMARY OF THE STUDY 
1) On par with previous studies incidence of skin cancers is 
increasing.  Incidence in our study is 2.2% according to Sv Deo it 
was 2.4%. Most of them are due to excessive exposure to sun light 
due their occupation. 
2) Among the skin cancers the occurrence of SCC, BCC and 
Malignant Melanoma in their descending order. 
3) Incidence of BCC and SCC is increasing in female population. 
4) Because of the low socioeconomic status, poor awareness, older 
age, painless presentations of SCC the patient’s medical attention 
is very late stage. 
5) In BCC, as the lesions appear on the face, the patients seek medical  
attention at earlier though the lesions are small and painless. 
6) SCC, in our series was seen mostly over the lower limb more over 
on the foot. The reason may be recurrent unnoticed / neglected 
injuries leading to non healing chronic ulcer, which may turn into 
malignant. 
7) Two of the SCC lesions were found to arise from post burn ulcer.  
8) Most of the SCC patients were well treated with WLE with 
primary closure  SSG / flap cover and they walked home disease 
free. Three patients treated  with below knee amputation because of 
their very late presentation, severity of the disease and associated 
deformity. There by the morbidity was reduced. 
9) BCC more common site of occurrence is head and neck. The BCC 
patients were treated successfully by WLE with primary closure / 
ssg / flap cover. We able to give them cure and cosmetic 
improvement. One patient  due to her late presentation and 
aggressiveness of the disease underwent  evisceration of orbit and 
flap cover. 
10) In melanoma the lesions were seen in foot. Three patients were 
treated by WLE with SSG, disarticulation and WLE with ilio 
inguinal lymph node dissection. There by the morbidity and the 
mortality were reduced. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
Conclusions 
1) Skin cancer is becoming  more common cancer among the Indians 
due to their excessive and prolonged exposure to UVR of sun light. 
2) It is totally curable once diagnosed and treated at early. 
3) The best modality of the diagnosis is by subjecting the lesions for 
biopsy. 
4) By obtaining the proper history, clinical examination and strong 
suspect on each and every non healing ulcer, changes in the mole 
one can diagnose skin cancers early. 
5) The best modality of treatment in our setup is surgery.     
 
 Prevention is better than cure. Avoiding unnecessary exposure to 
sun light and other chemical carcinogens will prevent the skin cancer. 
Educating the people, for proper clothing, using sunscreen lotions, 
ointments and to seek the medical help in early diagnosis. Use of topical 
antimitotic over vulnerable lesions,  in patients with XP and genetic 
counseling plays a major role. 
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Proforma 
                                                PROFORMA 
 
Name:                          Age / sex:                Occupation:             IP / OP:                   
Address:                                                       Date of admission: 
Complaints:  Ulcer / Pain / Swelling / Discharge / Pigmentation /  
Pruritus – with duration 
H /O          :  Sudden increase- in size of growth / number of moles /  
size of mole change in colour. 
H /O           : Fever / Cough / Head ache /Loss of appetite / loss of weight. 
H /O           : Sun burns / Recurrent injury / Corn shaving / Non healing  
ulcers / Burns / varicose ulcers contact with chemicals /  
Pesticides etc. 
H /O            : Exposure to excess sun light / Irradiation in the past / X rays  
/ UV rays. 
H /O            : Skin disorders-Lupus vulgaris / psoriasis / Leukoplakia. 
H / O           : Diabetes / Hypertension /Tuberculosis /Asthma / Ischemic  
heart disease /  Malignancy. 
H / O           : Surgery / Organ transplantation / Jaundice in the past  
H /O            : Smoking / Alcohol / tobacco use in any form 
Family h/o: Skin and other malignancies 
Treatment: Immunosuppressive drugs/ other topical applications 
 
 
 
General Examination : 
                      Built /complexion /skin/ hair/ nail/ anemia / jaundice   
                      Lymphadenopathy / Pedal edema etc. 
            Presence of pre malignant lesions- Leukoplakia, keratosis,  
Pigmented moles, naevi, burnscar etc.    
Vitals- temp / pulse rate /min and BP  
 L / E              : Lesion - Ulcer / swelling /warty lesion etc.  
Numbers:          
Site   :      
size:          shape:     
surface:          edges:       
floor:           mobility :       
induration:            discharge:     
Lymph node (s) examination.    
CVS -                 RS -                 P/A -             CNS -       Examination. 
Investigations: 
Wedge / Excisional biopsy. Fnac from nodes. 
Basic blood investigations, HIV status , chest X ray and ECG, X rays of 
local area. 
Usg abdomen and CT scan etc. 
Diagnosis  
Treatment:  
                   Surgery / medical, 
Outcome:  Functional / cosmesis   Prognosis. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Master Chart 
 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Colour Atlas 
 
                                           COLOUR ATLAS 
                       SQUAMOUS CELL CARCINOMA FOOT 
 
 
 
 
 
SCC OVER RIGHT HEEL WITH INGUINAL SECONDARIES  
 
 
 
 
 
                       
SCC FROM WOUND SCAR 
      
 
 
                   AFTER WLE AND FLAP RECONSTRUCTION 
 
                                           SCC  OVER LEFT LEG 
 
 
 
                                                  WLE WITH SSG  
SCC OVER LEFT THIGH 
 
 
SSC WITH DEFORMED FOOT AND ANKLE 
 
 
                                     SCC FROM POSTBURN SCAR 
 
 
 
 
 
 
 
 
 
 
 
 
 
VERRUCOUS CARCINOMA FOOT and ANKLE 
(in Hansen’s disease) 
 
 
                 
 
                                    
 
 
VERRUCOUS CARCINOMA OVER KNEE 
 
 
 
                     
VERRUCOUS CARCINOMA OVER RIGHT HEEL 
                                            
 
           XERODERMA PIGMENTOSUM WITH MULTIPLE BCC 
 
 
        
 
                                  
 
 
 
 
 
 
 
 
AFTER WLE SSG / FLAP COVER 
PIGMENTED BCC OVER FACE 
 
 
 
 
 
WLE WITH FLAP COVER DONE 
BCC OVER NOSE 
 
 
 
                                                   
 
BCC OVER CHEST 
MALIGNANT MELANOMA ON THE SOLE 
 
   
 
                                INGUINAL SECONDARIES 
                                     WLE OF MELANOMA 
 
 
 
 
ILIO INGUINAL BLOCK DISSECTION WITH TFL FLAP 
 
  
 
 
 
 
 
 
 
HISTOPATHOLOGY 
SCC 10 X 
SCC 40X 
 
 
 
 
 
 
 
 
 
 
 
 
VERRUCOUS CARCINOMA 10 X 
 
 
 
 
                           VERRUCOUS CARCINOMA 40 X 
 
BCC 10 X 
 
                                               
 
BCC 40 X 
 MALIGNANT MELANOMA 10 X
MALIGNANT MELANOMA 4
 
 
0 X 
 
 
